Mesa Laboratories Stock Performance
| MLAB Stock | USD 109.09 8.23 8.16% |
The company secures a Beta (Market Risk) of 3.15, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesa Laboratories will likely underperform. At this point, Mesa Laboratories has a negative expected return of -0.29%. Please make sure to verify Mesa Laboratories' daily balance of power, market facilitation index, and the relationship between the kurtosis and day median price , to decide if Mesa Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mesa Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return 8.16 | Five Day Return 6.78 | Year To Date Return 2.66 | Ten Year Return 48.04 | All Time Return 3.5 K |
Forward Dividend Yield 0.0059 | Payout Ratio 0.1151 | Forward Dividend Rate 0.64 | Dividend Date 2024-12-16 | Ex Dividend Date 2024-11-29 |
1 | Disposition of 1074 shares by Alltoft Jennifer Sadie of Mesa Laboratories subject to Rule 16b-3 | 08/30/2024 |
2 | Acquisition by Sullivan John James of 1074 shares of Mesa Laboratories subject to Rule 16b-3 | 09/06/2024 |
3 | Mesa Laboratories appoints Moss Adams as new auditor - Investing.com | 09/11/2024 |
4 | Disposition of 1499 shares by Brian Archbold of Mesa Laboratories at 125.0 subject to Rule 16b-3 | 09/13/2024 |
| Mesa Laboratories dividend paid on 16th of September 2024 | 09/16/2024 |
6 | Mesa Laboratories Inc Shares Gap Down to 125.59 on Sep 25 | 09/25/2024 |
7 | Mesa Laboratories declares 0.16 dividend | 10/02/2024 |
8 | Analysis of Chuck Royces Recent Transaction in Mesa Laboratories Inc | 10/15/2024 |
9 | Acquisition by Gary Owens of 11559 shares of Mesa Laboratories subject to Rule 16b-3 | 10/25/2024 |
10 | Disposition of 2551 shares by Gary Owens of Mesa Laboratories at 111.976 subject to Rule 16b-3 | 10/29/2024 |
11 | Mesa Laboratories Inc Stock Price Up 3.56 percent on Oct 30 | 10/30/2024 |
12 | Mesa Laboratories reports Q2 results | 11/07/2024 |
| Begin Period Cash Flow | 32.9 M |
Mesa |
Mesa Laboratories Relative Risk vs. Return Landscape
If you would invest 13,759 in Mesa Laboratories on August 26, 2024 and sell it today you would lose (2,850) from holding Mesa Laboratories or give up 20.71% of portfolio value over 90 days. Mesa Laboratories is currently does not generate positive expected returns and assumes 3.5101% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Mesa, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mesa Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesa Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mesa Laboratories, and traders can use it to determine the average amount a Mesa Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MLAB |
Estimated Market Risk
| 3.51 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mesa Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mesa Laboratories by adding Mesa Laboratories to a well-diversified portfolio.
Mesa Laboratories Fundamentals Growth
Mesa Stock prices reflect investors' perceptions of the future prospects and financial health of Mesa Laboratories, and Mesa Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mesa Stock performance.
| Return On Equity | -0.89 | ||||
| Return On Asset | 0.0169 | ||||
| Profit Margin | (1.08) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 791.03 M | ||||
| Shares Outstanding | 5.43 M | ||||
| Price To Earning | 433.94 X | ||||
| Price To Book | 3.67 X | ||||
| Price To Sales | 2.59 X | ||||
| Revenue | 216.19 M | ||||
| Gross Profit | 116.55 M | ||||
| EBITDA | (238.38 M) | ||||
| Net Income | (254.25 M) | ||||
| Cash And Equivalents | 43.75 M | ||||
| Cash Per Share | 8.23 X | ||||
| Total Debt | 231.3 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.90 X | ||||
| Book Value Per Share | 29.79 X | ||||
| Cash Flow From Operations | 44.13 M | ||||
| Earnings Per Share | (45.62) X | ||||
| Market Capitalization | 592.51 M | ||||
| Total Asset | 446.8 M | ||||
| Retained Earnings | (183.49 M) | ||||
| Working Capital | 65.04 M | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 657 K | ||||
About Mesa Laboratories Performance
By analyzing Mesa Laboratories' fundamental ratios, stakeholders can gain valuable insights into Mesa Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mesa Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mesa Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 143.80 | 211.22 | |
| Return On Tangible Assets | (1.66) | (1.58) | |
| Return On Capital Employed | (0.68) | (0.64) | |
| Return On Assets | (0.57) | (0.54) | |
| Return On Equity | (1.75) | (1.66) |
Things to note about Mesa Laboratories performance evaluation
Checking the ongoing alerts about Mesa Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mesa Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mesa Laboratories generated a negative expected return over the last 90 days | |
| Mesa Laboratories has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 216.19 M. Net Loss for the year was (254.25 M) with profit before overhead, payroll, taxes, and interest of 116.55 M. | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Mesa Laboratories reports Q2 results |
- Analyzing Mesa Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mesa Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Mesa Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mesa Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mesa Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mesa Laboratories' stock. These opinions can provide insight into Mesa Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |